A biomarker study to study latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 10 Dec 2015 New trial record